Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of rare diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development a... More >>
|Data as of Aug 19, 2019 4:48 PM EDT
Recent NewsMore >>
Upcoming EventsMore >>
|Sunday, September 08, 2019 through Tuesday, September 10, 2019||
|Monday, September 09, 2019 through Wednesday, September 11, 2019||
There are currently no items available.